Why Flexion Therapeutics Stock Is Flying Higher Today
Shares of Flexion Therapeutics (NASDAQ: FLXN) were flying 11.4% higher as of 11:22 a.m. EST on Friday. The big jump came after the biopharmaceutical company announced after the market closed on Thursday that the Food and Drug Administration had approved updates to the product label for Zilretta that should help to boost sales of the drug in treating osteoarthritis (OA) knee pain.
Zilretta first won FDA approval in 2017. But that approval included some language on the product label that Flexion felt presented hurdles in marketing the drug. The FDA decision announced on Thursday addresses several issues, including:
Image source: Getty Images.
Source Fool.com
